Press Releases

Invest Now

Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference (May 11, 2022).

Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer (April 22, 2022).

Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting (April 6, 2022)

Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting (Mar 2, 2022)

Stella Diagnostics CEO Discusses Competitive Advantage in Early Cancer Detection During Audio Interview with SmallCapVoice.com (Feb 16th 2022)

Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards (February, 15th, 2021)

StellaDX and Mayo Clinic Present Data Assessing STLA101 Assay Performance at the American College of Gastroenterology (Oct. 26th, 2021)

Stella Diagnostics and Collaborators Publish Peer-Reviewed Article on Barrett’s Esophagus-Related Cancer (Sept 9th, 2021).

Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes - SLDX (April 16th, 2021)

Stella Diagnostics to Present at the Benzinga Biotech Small Cap Conference (March 23rd, 2021)

Stella Diagnostics and the University of Kansas Medical Center Enter Into Collaborative Research Agreement (March 16th, 2021)

Stella Diagnostics Announces Key Additions to its Board of Directors (Feb 24th, 2021)

Stella Diagnostics and Mayo Clinic Enter Into Collaborative Research Agreement (Feb 17th, 2021)

Stella Diagnostics Announces Partnership with mProbe Laboratories (Feb 4th, 2021)

Stella Diagnostics to Present at 23rd Annual ICR Conference (Jan 7th, 2021)

Stella Diagnostics CEO Joe Abdo Featured on Global Cancer Advocacy Podcast 'Out of Patients with Matthew Zachary' (Nov 5th, 2020)

Stella Diagnostics to Present Data on Discovery of Proteomic Chemoresistance Network in Esophageal Cancer Tissue (Oct 22nd, 2020).

Stella Diagnostics to Participate in BIO Investor Forum Digital (Oct 9th, 2020).

Stella Diagnostics Selected as Buzz of BIO Winner for the 2020 BIO Investor Forum Digital (Sept 23rd, 2020).

JMD Properties, Inc. Acquires Diagnostic Oncology Company, Changes Focus to Biotech (Sept 2nd, 2020)

Keystone Capital Partners Announces Founding Investment in Stella Diagnostics (Sept 1st, 2020)

Page updated

Report abuse